A Single Dose Trial of NNC 0155-0000-0004 in Patients With Haemophilia A
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia and Europe. The aim of the trial is to investigate the
pharmacokinetics (the rate at which the trial drug is eliminated from the body) of a single
dose of turoctocog alfa (NNC 0155-0000-0004 (N8)) in patients with haemophilia A.
Participation in this trial is dependent on previous participation in trial NN7008-3543 (Part
B) (NCT00840086).